Medicare Enrolled

Dr. Irene Ma, MD

Hematology & Oncology · Winfield, IL
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Low-engagement
25 N WINFIELD RD STE 405, Winfield, IL 60190
6303647850
In practice since 2008 (18 years)
NPI: 1710151105 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Ma from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Ma? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Ma

Dr. Irene Ma is a hematology & oncology specialist in Winfield, IL, with 18 years of NPI registration. Based on federal Medicare data, Dr. Ma performed 29,143 Medicare services across 701 unique beneficiaries.

Between the years covered by Open Payments, Dr. Ma received a total of $787 from 18 pharmaceutical and/or device companies across 29 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Ma is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 18 years in practice ▲ Top 27% volume in IL $787 industry payments

Medicare Practice Summary

Medicare Utilization ↗
29,143
Medicare services
Top 27% in IL for hematology & oncology
701
Unique beneficiaries
$13
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~1,619 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Tocilizumab injection (Actemra) 15,400 $5 $7
Vedolizumab infusion (Entyvio)
This procedure involves the administration of vedolizumab via injection. The dosage is measured in milligrams.
7,500 $18 $35
Abatacept infusion (Orencia)
An injection of abatacept administered under the direct supervision of a physician. This code is used for Medicare when the drug is not self-administered.
2,225 $34 $81
Denosumab injection (Prolia/Xgeva) 1,500 $19 $27
Infliximab infusion (Remicade)
An injection of infliximab, excluding biosimilar versions, administered in a 10 mg dose.
1,030 $26 $149
Dexamethasone injection (steroid)
An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram.
330 $0 $1
Blood draw (venipuncture)
Insertion of a needle into a vein to collect a blood sample.
142 $8 $20
Complete blood count (CBC) with differential
An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells.
139 $8 $40
Intravenous infusion, 1 hour or less
Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less.
117 $54 $201
Intravenous injection of additional new drug or substance
Administration of an additional new medication or substance directly into a vein.
114 $13 $54
Intravenous chemotherapy infusion, 1 hour or less
Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete.
111 $110 $380
Comprehensive metabolic blood panel
A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers.
108 $10 $55
Additional hour of intravenous chemotherapy
This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period.
60 $24 $95
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
54 $148 $307
Drug injection, under skin or into muscle
A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle.
52 $12 $62
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
49 $104 $229
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
39 $72 $157
Ferritin level test (iron stores)
A blood test that measures the level of ferritin, a protein that stores iron in the body.
30 $13 $70
Iron level test 30 $6 $33
Iron binding capacity test
A blood test that measures the amount of iron in the blood and the blood's ability to bind and transport iron.
30 $9 $45
Diphenhydramine injection, up to 50 mg
An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams.
26 $1 $3
Additional sequential IV infusion, 1 hour or less
This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less.
25 $24 $95
Hospital follow-up visit, moderate complexity
Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service.
17 $65 $151
Initial hospital admission, high complexity
Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter.
15 $143 $441
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
37.8% high complexity
60.0% medium
2.2% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$787
Total received (2018-2024)
Avg $157/year across 5 years
Bottom 34% in IL for hematology & oncology
18
Companies
29
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$763 (97.0%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$24 (3.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$390
2023
$146
2021
$12
2019
$211
2018
$28

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Tempus AI, Inc
$76
Daiichi Sankyo Inc.
$72
ABBVIE INC.
$52
Merck Sharp & Dohme LLC
$34
Regeneron Healthcare Solutions, Inc.
$29
E.R. Squibb & Sons, L.L.C.
$26
Biocon Biologics Inc
$24
Lilly USA, LLC
$24
ARGENX US, INC.
$23
Novartis Pharmaceuticals Corporation
$18
AstraZeneca Pharmaceuticals LP
$14
Top 3 companies account for 51.2% of 2024 payments
All-time payments by company (2018-2024) ›
Janssen Biotech, Inc.
$116
Daiichi Sankyo Inc.
$101
Verastem, Inc.
$83
Tempus AI, Inc
$76
ABBVIE INC.
$65
E.R. Squibb & Sons, L.L.C.
$50
Novartis Pharmaceuticals Corporation
$41
Celgene Corporation
$34
Merck Sharp & Dohme LLC
$34
PFIZER INC.
$29
Regeneron Healthcare Solutions, Inc.
$29
Biocon Biologics Inc
$24
Lilly USA, LLC
$24
ARGENX US, INC.
$23
Alexion Pharmaceuticals, Inc.
$22
AstraZeneca Pharmaceuticals LP
$14
Gilead Sciences, Inc.
$12
MEDIVATION FIELD SOLUTIONS LLC
$11
Top 3 companies account for 38.1% of all-time payments
Associated products mentioned in payments ›
Copiktra · DARZALEX · ELIQUIS · Enhertu · Fulphila · IBRANCE · IMBRUVICA · KEYTRUDA · KISQALI · LIBTAYO · OMVOH · OPDIVO · Pomalyst · SCEMBLIX · SUTENT · TAGRISSO · ULTOMIRIS · VENCLEXTA · VYVGART HYTRULO · XTANDI
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (97%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a hematology & oncology specialist in Winfield?
Compare hematology & oncology specialists in the Winfield area by procedure volume, costs, and industry payment transparency.
Browse hematology & oncology specialists nearby

Geographic Context

Hematology & oncology specialists within 10 mi
231
Per 100K population
24.9
County median income
$110,502
Nearest hospital
NORTHWESTERN MEDICINE CENTRAL DUPAGE HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Ma is a mixed practice specialist, with above-average Medicare volume (top 27% in IL), with low-engagement industry engagement, with 18 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Ma experienced with tocilizumab injection (actemra)?
Based on Medicare claims data, Dr. Ma performed 15,400 tocilizumab injection (actemra) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Ma receive payments from pharmaceutical companies?
Yes. Dr. Ma received a total of $787 from 18 companies across 29 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Ma's costs compare to other hematology & oncology specialists in Winfield?
Dr. Ma's average Medicare payment per service is $13. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Ma) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →